Mankind Pharma Ltd. is set to acquire biopharma firm Bharat Serums and Vaccines for Rs 13,630 crore, in a strategic move to enhance its presence in the women’s health and fertility market segments.According to NDTV PROFIT, This acquisition will significantly expand Mankind Pharma’s portfolio and capabilities in critical health sectors. The company will purchase Bharat Serums and Vaccines Ltd. from the private equity firm Advent International, with the transaction expected to close in three to four months.
Mumbai-based Bharat Serums offers a wide range of products focusing on women’s health, oncology, and critical care, which align with Mankind Pharma’s goal of providing comprehensive healthcare solutions. The acquisition is expected to bring synergies in research and development, manufacturing, and distribution, potentially leading to innovative product offerings and improved market reach.
Mumbai, April 17 Benchmark equity indices Sensex and Nifty opened on a positive note in…
Mumbai, April 16 The Indian rupee appreciated by 6 paise to 93.27 against the US…
Mumbai, April 15 The Indian rupee appreciated by 20 paise to 93.15 against the US…
New Delhi, April 14 India’s crude oil imports from Russia more than tripled to 5.3…
